» 회사 뉴스 » Zhong Nanshan: COVID-19의 추적성은 아직 완료되지 않았습니다.

중난산: COVID-19의 추적성은 아직 완료되지 않았습니다.

2020-11-17

On November 16th, 2020 Guanzhou International Bio-Forum was held in Guangzhou International Bio-Island, 를 주제로 “Scientific and Technological Innovation Leads a Healthy Future”. 중난산, winner of the Medal of the Republic and academician of Chinese Academy of Engineering, attended the forum and delivered a speech.Zhong Nanshan: COVID-19의 추적성은 아직 완료되지 않았습니다..

Zhong Nanshan said that it is unimaginable for so many people to meet together today in foreign countries. 현재, there are still many major problems unsolved in COVID-19, the law of COVID-19 outbreak has not been understood, the traceability has not been completed, and there are no highly targeted and effective drugs. Pfizer vaccine abroad can prevent 90% of infections, and vaccine research and development in China is at a similar level.

Zhong Nanshan said that at present, there is a great contrast between China and foreign countries in the prevention and control of the epidemic situation, which is because China took the idea oflife firstas a guide and timely controlled the domestic epidemic situation at the early stage of the outbreak.

This is very different from my experience in fighting SARS in 2003. At that time, scientific research was not done enough, but when the COVID-19 outbreak broke out, we had the support of science and technology. We could prevent and study while developing kits earlier and promote them quickly. ” Zhong Nanshan said that due to the combination of medical treatment and scientific research, the COVID-19 epidemic in China was quickly controlled.

Zhong Nanshan said that until today, many major problems of the epidemic have not been solved, such as the source of COVID-19 is still unclear, and targeted drugs have not yet appeared. Zhong Nanshan said that it depends on the combination of basic and clinical, clinical and enterprise. “Shorten this road a little, this is the direction of our efforts.

According to Zhong Nanshan, Pfizer vaccine abroad can prevent 90% of infections. 사실로, the level of vaccine research and development in Guangdong and even China is similar, but the results of the first phase of the trial can only be announced.

On September 24th, at the 13th China Bio-industry Conference, Academician Zhong Nanshan said that the pneumonia epidemic in COVID-19 may continue to exist or develop this winter and next spring. He introduced that it takes 1 상하이, 루머 플랫폼 반박 2 years to complete mass vaccination.

새로운 크라운 백신 새로운 크라운 백신

어쩌면 당신도 좋아

  • 카테고리

  • 최근 게시물

  • 태그

  • 회사 소개


    메디컬 테크놀로지(주), 주식회사. 중국의 의료 용품 전문 제조업체입니다., 우리는 나일론 무리를 지어 면봉을 생산하고 판매합니다, VTM 키트, 타액 수집 키트 및 CHG 면봉 & 델타 변종에 효과적인 중국에서 가장 많이 사용되는 COVID-19 백신.

  • 문의하기

    주소: 방 201, 301 그리고 401 A동 10호, 바오롱 5번가, 통글 커뮤니티, 바오롱 스트리트, 롱강 지구,선전, 광동, 중국.

    편물: www.medicoswab.com

    전화 번호: +86 0755-28997664

    이메일: info@medicoswab.com